rs35490401
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The NM_006949.4(STXBP2):c.1586G>A(p.Arg529Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000899 in 1,613,524 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R529P) has been classified as Likely benign.
Frequency
Consequence
NM_006949.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
STXBP2 | NM_006949.4 | c.1586G>A | p.Arg529Gln | missense_variant | 18/19 | ENST00000221283.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
STXBP2 | ENST00000221283.10 | c.1586G>A | p.Arg529Gln | missense_variant | 18/19 | 1 | NM_006949.4 | P4 |
Frequencies
GnomAD3 genomes ? AF: 0.000348 AC: 53AN: 152198Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000105 AC: 26AN: 247752Hom.: 0 AF XY: 0.000104 AC XY: 14AN XY: 134828
GnomAD4 exome AF: 0.0000636 AC: 93AN: 1461208Hom.: 0 Cov.: 76 AF XY: 0.0000633 AC XY: 46AN XY: 726912
GnomAD4 genome ? AF: 0.000341 AC: 52AN: 152316Hom.: 0 Cov.: 33 AF XY: 0.000336 AC XY: 25AN XY: 74480
ClinVar
Submissions by phenotype
Familial hemophagocytic lymphohistiocytosis 5 Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Apr 14, 2018 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 30, 2024 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | The c.1586G>A (p.R529Q) alteration is located in exon 18 (coding exon 18) of the STXBP2 gene. This alteration results from a G to A substitution at nucleotide position 1586, causing the arginine (R) at amino acid position 529 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Sep 16, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at